During the past decade, Hunter New England Area Health Service conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hunter New England Area Health Service" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hunter New England Area Health Service" are "Constipation" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Hunter New England Area Health Service" in a lesser frequency.

Most popular intervention types in "Hunter New England Area Health Service" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Active Hydromorphone PR + Active Naloxone PR" (1 trials), "Active Hydromorphone PR + Placebo Naloxone PR" (1 trials) and "Alteplase t-PA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hunter New England Area Health Service" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hunter New England Area Health Service". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hunter New England Area Health Service, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hunter New England Area Health Service, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".